Literature DB >> 29966095

Selective Small Molecule Recognition of RNA Base Pairs.

Hafeez S Haniff1, Amanda Graves1, Matthew D Disney1.   

Abstract

Many types of RNAs exist in the human transcriptome, yet only the bacterial ribosome has been exploited as a small molecule drug target. Aside from rRNA, other cellular RNAs such as noncoding RNAs have primarily secondary structure and limited tertiary structure. Within these secondary structures of noncanonically paired and unpaired regions, more than 50% are base paired, with most efforts to target these structures focused on looped regions. A void exists in the availability of small molecules capable of targeting RNA base pairs. Using chemoinformatics, an RNA-focused library enriched for nitrogen-containing heterocycles was developed and tested for binding RNA base pairs, leading to the identification of six selective and previously unknown binders. While all binders were derivatives of benzimidazoles, those with expanded aromatic polycycles bound selectively to AU pairs, while those with flexible urea side chains bound selectively to GC pairs. Two of the three selective GC pair binders can distinguish between two different orientations, 5'GG/3'CC and 5'GC/3'CG pairs. Furthermore, all six molecules showed >50-fold selectivity for RNA over DNA. These studies provide foundational knowledge to better exploit RNA as targets for small molecule chemical probes or lead therapeutics by using modules that target RNA base pairs.

Entities:  

Keywords:  RNA; base pairs; high-throughput screening; nucleic acids; small molecules

Mesh:

Substances:

Year:  2018        PMID: 29966095      PMCID: PMC6325646          DOI: 10.1021/acscombsci.8b00049

Source DB:  PubMed          Journal:  ACS Comb Sci        ISSN: 2156-8944            Impact factor:   3.784


  83 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

Review 2.  Targeting RNA with small molecules.

Authors:  Jason R Thomas; Paul J Hergenrother
Journal:  Chem Rev       Date:  2008-03-25       Impact factor: 60.622

3.  An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication.

Authors:  F Hamy; E R Felder; G Heizmann; J Lazdins; F Aboul-ela; G Varani; J Karn; T Klimkait
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

Review 4.  Managing the sequence-specificity of antisense oligonucleotides in drug discovery.

Authors:  Peter H Hagedorn; Bo R Hansen; Troels Koch; Morten Lindow
Journal:  Nucleic Acids Res       Date:  2017-03-17       Impact factor: 16.971

5.  Design of sequence-specific DNA-binding molecules.

Authors:  P B Dervan
Journal:  Science       Date:  1986-04-25       Impact factor: 47.728

Review 6.  Antisense oligonucleotide therapeutics for inherited neurodegenerative diseases.

Authors:  Amber L Southwell; Niels H Skotte; C Frank Bennett; Michael R Hayden
Journal:  Trends Mol Med       Date:  2012-09-28       Impact factor: 11.951

7.  Determination of binding stoichiometry by the continuous variation method: the Job plot.

Authors:  C Y Huang
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

8.  Preferred RNA binding sites for a threading intercalator revealed by in vitro evolution.

Authors:  Coby B Carlson; Momchilo Vuyisich; Barry D Gooch; Peter A Beal
Journal:  Chem Biol       Date:  2003-07

9.  A toxic RNA catalyzes the in cellulo synthesis of its own inhibitor.

Authors:  Suzanne G Rzuczek; HaJeung Park; Matthew D Disney
Journal:  Angew Chem Int Ed Engl       Date:  2014-08-27       Impact factor: 15.336

Review 10.  5'-UTR RNA G-quadruplexes: translation regulation and targeting.

Authors:  Anthony Bugaut; Shankar Balasubramanian
Journal:  Nucleic Acids Res       Date:  2012-02-20       Impact factor: 16.971

View more
  11 in total

Review 1.  Small molecule targeting of RNA structures in neurological disorders.

Authors:  Alicia J Angelbello; Jonathan L Chen; Matthew D Disney
Journal:  Ann N Y Acad Sci       Date:  2019-04-09       Impact factor: 5.691

2.  Targeting RNA with Small Molecules To Capture Opportunities at the Intersection of Chemistry, Biology, and Medicine.

Authors:  Matthew D Disney
Journal:  J Am Chem Soc       Date:  2019-04-19       Impact factor: 15.419

Review 3.  Fluorescent indicator displacement assays to identify and characterize small molecule interactions with RNA.

Authors:  Sarah L Wicks; Amanda E Hargrove
Journal:  Methods       Date:  2019-04-30       Impact factor: 3.608

4.  Context-Sensitive Cleavage of Folded DNAs by Loop-Targeting bPNAs.

Authors:  Yufeng Liang; Shiqin Miao; Jie Mao; Chris DeSantis; Dennis Bong
Journal:  Biochemistry       Date:  2020-06-23       Impact factor: 3.162

Review 5.  Unnatural bases for recognition of noncoding nucleic acid interfaces.

Authors:  Shiqin Miao; Yufeng Liang; Sarah Rundell; Debmalya Bhunia; Shekar Devari; Oliver Munyaradzi; Dennis Bong
Journal:  Biopolymers       Date:  2020-09-24       Impact factor: 2.505

6.  Systematic analysis of the interactions driving small molecule-RNA recognition.

Authors:  G Padroni; N N Patwardhan; M Schapira; A E Hargrove
Journal:  RSC Med Chem       Date:  2020-06-04

7.  Structural Features of Small Molecules Targeting the RNA Repeat Expansion That Causes Genetically Defined ALS/FTD.

Authors:  Andrei Ursu; Kye Won Wang; Jessica A Bush; Shruti Choudhary; Jonathan L Chen; Jared T Baisden; Yong-Jie Zhang; Tania F Gendron; Leonard Petrucelli; Ilyas Yildirim; Matthew D Disney
Journal:  ACS Chem Biol       Date:  2020-11-16       Impact factor: 5.100

8.  A structure-specific small molecule inhibits a miRNA-200 family member precursor and reverses a type 2 diabetes phenotype.

Authors:  Hafeez S Haniff; Xiaohui Liu; Yuquan Tong; Samantha M Meyer; Laurent Knerr; Malin Lemurell; Daniel Abegg; Haruo Aikawa; Alexander Adibekian; Matthew D Disney
Journal:  Cell Chem Biol       Date:  2021-07-27       Impact factor: 8.116

9.  A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.

Authors:  Sarah Wagner-Griffin; Masahito Abe; Raphael I Benhamou; Alicia J Angelbello; Kamalakannan Vishnu; Jonathan L Chen; Jessica L Childs-Disney; Matthew D Disney
Journal:  J Med Chem       Date:  2021-06-08       Impact factor: 8.039

Review 10.  Target-Directed Approaches for Screening Small Molecules against RNA Targets.

Authors:  Hafeez S Haniff; Laurent Knerr; Jonathan L Chen; Matthew D Disney; Helen L Lightfoot
Journal:  SLAS Discov       Date:  2020-05-18       Impact factor: 3.341

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.